Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06523569 · ClinicalTrials.gov registry record · NA
Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy
A NA study of Preeclampsia and Gestational Hypertension, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06523569: Recruiting NA study of Preeclampsia and Gestational Hypertension, sponsored by Northwestern University.
NCT06523569 is a NA study of Preeclampsia and Gestational Hypertension that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 120 participants, below the 1,124-participant average among 48 other Preeclampsia trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06523569, a NA study of Preeclampsia and Gestational Hypertension, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to study digital health interventions to prevent cardiovascular disease in individuals who have had a hypertensive disorder of pregnancy (HDP).
Primary Outcome
All participants will have systolic blood pressure measured at 3 months and 12 months postpartum
Conditions Studied
Interventions
- OTHER Mobile health application
- OTHER Digital Blood Pressure Monitoring System
Study Locations (1)
Illinois
- Northwestern University, Dept. of Cardiology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-11-07 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06523569 shows while recruiting
NCT06523569 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,124-participant average among 48 other Preeclampsia trials with a reported enrollment target (89% lower).
The record links to 4 conditions, with Preeclampsia appearing as the primary indexed condition, and to 2 interventions - of which Mobile health application is the first listed.
NCT06523569 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06523569 about?
NCT06523569 is a clinical study titled "Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy". The purpose of this research is to study digital health interventions to prevent cardiovascular disease in individuals who have had a hypertensive disorder of pregnancy (HDP).
What is the current status of trial NCT06523569?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-11-07. Estimated completion is 2026-06-30.
What conditions does trial NCT06523569 study?
This clinical trial studies the following conditions: Preeclampsia, Gestational Hypertension, Hypertension in Pregnancy, Eclampsia.
What interventions are being tested in trial NCT06523569?
The interventions under investigation include: Mobile health application (OTHER), Digital Blood Pressure Monitoring System (OTHER).
Who is sponsoring clinical trial NCT06523569?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06523569 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06523569's enrollment target sits among peer trials
120 29th of 48 higher than 19 of 48 other Preeclampsia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preeclampsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
RECRUITING · NA
-
Preventing Obstetric Complications With Dietary Intervention
RECRUITING · NA
-
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
RECRUITING · NA
-
Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI